Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis

References

• Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol 2005;252(Suppl. 5):v3–9.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Knight JC, Ebers GC. Multiple sclerosis and the major histocompatibility complex. Curr Opin Neurol 2009;22:219–25.
   PubMed Web of Science ®Google Scholar
• Isik N, Arman A, Canturk IA, et al. Multiple sclerosis: association with the interleukin-1 gene family polymorphisms in the Turkish population. Int J Neurosci 2013;123:711–18.
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007;357:851–62.
   PubMed Web of Science ®Google Scholar
• Zuvich RL, McCauley JL, Oksenberg JR, et al. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 2010;127:525–35.
   PubMed Web of Science ®Google Scholar
• Kristjansdottir G, Sandling JK, Bonetti A, et al. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 2008;45:362–69.
   PubMed Web of Science ®Google Scholar
• Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009;41:199–204.
   PubMed Web of Science ®Google Scholar
• Beaudoin M, Goyette P, Boucher G, et al. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet 2013;9:e1003723.
   PubMed Web of Science ®Google Scholar
• Gaffen SL, Jain R, Garg AV, et al. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 2014;14:585–600.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–48.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177–88.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–101.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Hall MA, McGlinn E, Coakley G, et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000;1:219–24.
   PubMed Web of Science ®Google Scholar
• van Veen T, Crusius JB, Schrijver HM, et al. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 2001;50:275.
   PubMed Web of Science ®Google Scholar
• Forte GI, Ragonese P, Salemi G, et al. Search for genetic factors associated with susceptibility to multiple sclerosis. Ann N Y Acad Sci 2006;1067:264–69.
   PubMed Web of Science ®Google Scholar
• Illes Z, Safrany E, Peterfalvi A, et al. 3′UTR C2370A allele of the IL-23 receptor gene is associated with relapsing-remitting multiple sclerosis. Neurosci Lett 2008;431:36–38.
   PubMed Web of Science ®Google Scholar
• Roos IM, Kockum I, Hillert J. The interleukin 23 receptor gene in multiple sclerosis: A case-control study. J Neuroimmunol 2008;194:173–80.
   PubMed Web of Science ®Google Scholar
• Shokrgozar MA, Sarial S, Amirzargar A, et al. IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis. J Clin Immunol 2009;29:747–51.
   PubMed Web of Science ®Google Scholar
• Liu M, Hu X, Wang Y, et al. Association of IL-23 and its receptor gene single nucleotide polymorphisms with multiple sclerosis in Chinese southern population. Int J Neurosci 2014;124:904–907.
   PubMed Web of Science ®Google Scholar
• Gran B, Zhang GX, Rostami A. Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination. Crit Rev Immunol 2004;24:111–28.
   PubMed Web of Science ®Google Scholar
• Li Y, Chu N, Hu A, et al. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain 2007;130(Pt2):490–501.
   PubMed Web of Science ®Google Scholar
• Montes M, Zhang X, Berthelot L, et al. Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol 2009;130:133–44.
   PubMed Web of Science ®Google Scholar
• Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol 2011;32:232–39.
   PubMed Web of Science ®Google Scholar
• Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744–48.
   PubMed Web of Science ®Google Scholar
• Yang J, Sundrud MS, Skepner J, et al. Targeting Th17 cells in autoimmune diseases. Trends Pharmacol Sci 2014; 35:493–500.
   PubMed Web of Science ®Google Scholar
• ‘t Hart BA, Brok HP, Remarque E, et al. Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. J Immunol 2005;175:4761–68.
   PubMed Web of Science ®Google Scholar
• Chen Y, Langrish CL, McKenzie B, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006;116:1317–26.
   PubMed Web of Science ®Google Scholar
• Sáfrány E, Pazár B, Csöngei V, et al. Variants of the IL23R gene are associated with ankylosing spondylitisbut not with Sjögren syndrome in Hungarian population samples. Scand J Immunol 2009;70:68–74.
   PubMed Web of Science ®Google Scholar
• Begovich AB, Chang M, Caillier SJ, et al. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 2007;68:934–37.
   PubMed Web of Science ®Google Scholar
• Segal BM, Constantinescu CS, Raychaudhuri A, et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008;7:796–804.
   PubMed Web of Science ®Google Scholar
• Varadé J, Comabella M, Ortiz MA, et al. Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes. Mult Scler 2012;;18:959–65.
   Google Scholar
• International Multiple Sclerosis Genetics Consortium (IMSGC). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 2010;11:397–405.
   PubMed Web of Science ®Google Scholar